Free Trial

InspireMD (NSPR) 10K Form and Latest SEC Filings 2026

InspireMD logo
$1.14 -0.03 (-2.56%)
Closing price 04:00 PM Eastern
Extended Trading
$1.15 +0.01 (+0.53%)
As of 06:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest InspireMD SEC Filings & Recent Activity

InspireMD (NYSE:NSPR) has submitted 390+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 4 submitted on May 13, 2026.

Form 4
InspireMD, Inc. Reports Ownership Change on May. 13, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
InspireMD Files Current Report on May. 4, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
InspireMD Files Quarterly Report on May. 7, 2026

The 10-Q contains InspireMD's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

InspireMD SEC Filing History

Browse InspireMD's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/13/2026 4:00 PM
InspireMD (1433607) Issuer
Slosman Marvin (1796908) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2026 3:47 PM
InspireMD (1433607) Issuer
Stuka Paul (1528577) Reporting
Form 4/A
05/12/2026 6:35 PM
InspireMD (1433607) Issuer
Stuka Paul (1528577) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2026 4:03 PM
InspireMD (1433607) Issuer
ROUBIN GARY S (1162533) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2026 4:05 PM
InspireMD (1433607) Issuer
Stuka Paul (1528577) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2026 7:53 AM
InspireMD (1433607) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2026 3:05 PM
InspireMD (1433607) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2026 4:00 PM
InspireMD (1433607) Subject
Slosman Marvin (1796908) Filed by
Form SCHEDULE 13D
04/22/2026 3:15 PM
InspireMD (1433607) Filer
Form DEFA14A
04/20/2026 3:40 PM
InspireMD (1433607) Filer
Form ARS
04/20/2026 3:30 PM
InspireMD (1433607) Filer
Form DEF 14A
04/20/2026 3:35 PM
InspireMD (1433607) Filer
Form DEFA14A
04/10/2026 3:30 PM
InspireMD (1433607) Filer
Form PRE 14A
04/03/2026 3:01 PM
InspireMD (1433607) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2026 7:34 AM
InspireMD (1433607) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2026 6:18 AM
InspireMD (1433607) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/17/2026 5:27 PM
InspireMD (1433607) Subject
ORBIMED ADVISORS LLC (1055951) Filed by
Form SCHEDULE 13G
02/11/2026 10:50 AM
InspireMD (1433607) Subject
Rosalind Advisors, Inc. (1622627) Filed by
Form SCHEDULE 13G/A
02/02/2026 9:35 AM
Aberdeen Group plc (1716774) Filed by
InspireMD (1433607) Subject
Form SCHEDULE 13G/A
01/16/2026 5:09 PM
BERMAN MICHAEL (1186801) Reporting
InspireMD (1433607) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 5:09 PM
COHEN RAYMOND W (1258288) Reporting
InspireMD (1433607) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 5:09 PM
Dearen Danny L. (1756438) Reporting
InspireMD (1433607) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 5:09 PM
Gleason Shane Thomas (1966214) Reporting
InspireMD (1433607) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 5:10 PM
InspireMD (1433607) Issuer
Lawless Michael A (1947077) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 5:10 PM
InspireMD (1433607) Issuer
ROUBIN GARY S (1162533) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 5:11 PM
InspireMD (1433607) Issuer
Slosman Marvin (1796908) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 5:11 PM
InspireMD (1433607) Issuer
Stuka Paul (1528577) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 5:11 PM
InspireMD (1433607) Issuer
Tommasoli Andrea (1969462) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 5:12 PM
InspireMD (1433607) Issuer
Ward Scott R. (1174531) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 3:15 PM
Arnold Kathryn (1861350) Reporting
InspireMD (1433607) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2025 3:15 PM
InspireMD (1433607) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2025 3:05 PM
InspireMD (1433607) Issuer
Stuka Paul (1528577) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2025 3:05 PM
InspireMD (1433607) Issuer
Stuka Paul (1528577) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2025 5:12 PM
InspireMD (1433607) Subject
ORBIMED ADVISORS LLC (1055951) Filed by
Form SCHEDULE 13G/A
11/14/2025 3:47 PM
InspireMD (1433607) Subject
Nantahala Capital Management, LLC (1472322) Filed by
Form SCHEDULE 13G/A
11/14/2025 11:44 AM
InspireMD (1433607) Subject
Parkman Healthcare Partners LLC (1777015) Filed by
Form SCHEDULE 13G
11/07/2025 5:25 AM
Aberdeen Group plc (1716774) Filed by
InspireMD (1433607) Subject
Form SCHEDULE 13G
10/29/2025 3:30 PM
InspireMD (1433607) Subject
Shore Craig (1517387) Filed by
Form SCHEDULE 13D/A
10/29/2025 3:30 PM
InspireMD (1433607) Subject
Lawless Michael A (1947077) Filed by
Form SCHEDULE 13D
10/09/2025 3:05 PM
InspireMD (1433607) Issuer
ROUBIN GARY S (1162533) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2025 3:00 PM
Dearen Danny L. (1756438) Reporting
InspireMD (1433607) Issuer
Form 3
Initial statement of beneficial ownership of securities  
The system holding the dollar together is gone… (Ad)

Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every country on Earth to hold U.S. dollars to buy oil. Since then, Saudi Arabia has signed a $7 billion currency swap with China, begun settling oil in digital yuan, and joined China's cross-border payment system, mBridge. With 10-year Treasury yields pushing toward the 4.4% danger line and global dollar demand in retreat, gold is being repriced. There's one asset that still trades at a steep discount to gold's current price - a rare opportunity to leverage the metal's continued rise.tc pixel

Learn how to position ahead of the dollar's continued decline
09/17/2025 3:20 PM
InspireMD (1433607) Issuer
Kester Thomas J (1299870) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2025 7:00 AM
InspireMD (1433607) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025 11:15 PM
InspireMD (1433607) Filer
Form EFFECT
08/11/2025 1:39 PM
InspireMD (1433607) Subject
Rosalind Advisors, Inc. (1622627) Filed by
Form SCHEDULE 13G/A
08/11/2025 10:20 AM
InspireMD (1433607) Subject
Rosalind Advisors, Inc. (1622627) Filed by
Form SCHEDULE 13G/A
08/11/2025 10:32 AM
InspireMD (1433607) Subject
Rosalind Advisors, Inc. (1622627) Filed by
Form SCHEDULE 13G/A
08/05/2025 8:01 AM
InspireMD (1433607) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2025 4:37 PM
COHEN RAYMOND W (1258288) Reporting
InspireMD (1433607) Issuer
Form 3
Initial statement of beneficial ownership of securities  
08/01/2025 4:00 PM
InspireMD (1433607) Issuer
Stuka Paul (1528577) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2025 4:00 PM
InspireMD (1433607) Issuer
Slosman Marvin (1796908) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2025 4:00 PM
InspireMD (1433607) Issuer
Kester Thomas J (1299870) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2025 4:00 PM
InspireMD (1433607) Issuer
ROUBIN GARY S (1162533) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025 7:35 AM
InspireMD (1433607) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2025 6:05 AM
InspireMD (1433607) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025 6:33 PM
InspireMD (1433607) Issuer
Lawless Michael A (1947077) Reporting
Form 3
Initial statement of beneficial ownership of securities  
06/13/2025 8:05 AM
InspireMD (1433607) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025 3:10 PM
InspireMD (1433607) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025 7:13 PM
InspireMD (1433607) Subject
ORBIMED ADVISORS LLC (1055951) Filed by
Form SCHEDULE 13G/A
(Data available from 1/1/2016 forward)

InspireMD SEC Filings - Frequently Asked Questions

InspireMD (NSPR) has submitted 390+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

InspireMD's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 4 submitted on May 13, 2026. This was an insider ownership change filed by 4 - InspireMD, Inc. (0001433607) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:NSPR) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners